Cargando…
Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors
Background Acute respiratory distress syndrome (ARDS) is a major complication in patients with severe coronavirus disease in 2019 (COVID-19). COVID-19 convalescent plasma (CCP) has been proposed as a specific therapy for patients with COVID-19. Our goal is to assess changes in oxygenation and inflam...
Autores principales: | Baez Sosa, Valentina, Nassar, Ahmad M, Vobugari, Nikitha, Ghodasara, Anjali S, Conry-Cantilena, Cathy, Wortmann, Glenn, Fischer, Emily R, Fernandez, Stephen, Desale, Sameer, Wyne, Lorraine, Clark, Brandon G, Shenoy, Aarthi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701556/ http://dx.doi.org/10.1182/blood-2021-152894 |
Ejemplares similares
-
Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic
por: Baez Sosa, Valentina, et al.
Publicado: (2020) -
Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience.
por: Plaza, Carlos, et al.
Publicado: (2020) -
Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience
por: Browning, Sabrina L., et al.
Publicado: (2020) -
Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2
por: Pérez-Jacobo, Fernando, et al.
Publicado: (2020) -
Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil
por: Roberti, Maria do Rosario Ferraz, et al.
Publicado: (2020)